JY
CBPO

Jeff Yass’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Jeff Yass’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,800
Closed -$213K – 13268
2020
Q4 		$213K Sell
1,800
-4,700
-72% -$546K ﹤0.01% 9939
2020
Q3 		$722K Hold
6,500
– – ﹤0.01% 6898
2020
Q2 		$664K Sell
6,500
-17,400
-73% -$1.86M ﹤0.01% 6762
2020
Q1 		$2.58M Sell
23,900
-20,200
-46% -$2.32M ﹤0.01% 3530
2019
Q4 		$5.13M Sell
44,100
-55,500
-56% -$6.43M ﹤0.01% 2935
2019
Q3 		$11.4M Buy
99,600
+49,700
+100% +$4.94M ﹤0.01% 1839
2019
Q2 		$4.75M Sell
49,900
-500
-1% -$47.1K ﹤0.01% 2781
2019
Q1 		$4.6M Sell
50,400
-2,400
-5% -$196K ﹤0.01% 2554
2018
Q4 		$4.01M Sell
52,800
-106,900
-67% -$7.87M ﹤0.01% 2552
2018
Q3 		$12.8M Buy
159,700
+110,200
+223% +$10.3M ﹤0.01% 1713
2018
Q2 		$4.92M Sell
49,500
-24,500
-33% -$2.12M ﹤0.01% 2730
2018
Q1 		$5.99M Buy
74,000
+8,000
+12% +$647K ﹤0.01% 2322
2017
Q4 		$5.2M Buy
66,000
+36,500
+124% +$3.03M ﹤0.01% 2499
2017
Q3 		$2.72M Buy
29,500
+16,200
+122% +$1.56M ﹤0.01% 3379
2017
Q2 		$1.5M Buy
13,300
+3,000
+29% +$335K ﹤0.01% 4426
2017
Q1 		$1.03M Sell
10,300
-14,500
-58% -$1.55M ﹤0.01% 5066
2016
Q4 		$2.67M Sell
24,800
-55,100
-69% -$6.44M ﹤0.01% 3473
2016
Q3 		$9.95M Sell
79,900
-4,100
-5% -$484K ﹤0.01% 1549
2016
Q2 		$8.93M Buy
84,000
+22,500
+37% +$2.61M ﹤0.01% 1547
2016
Q1 		$7.04M Buy
61,500
+43,500
+242% +$5.1M ﹤0.01% 1890
2015
Q4 		$2.56M Sell
18,000
-38,900
-68% -$4.49M ﹤0.01% 3586
2015
Q3 		$5.11M Sell
56,900
-21,300
-27% -$2.25M ﹤0.01% 2650
2015
Q2 		$9.01M Buy
78,200
+27,400
+54% +$2.88M ﹤0.01% 2129
2015
Q1 		$4.85M Sell
50,800
-9,400
-16% -$703K ﹤0.01% 2785
2014
Q4 		$4.05M Buy
60,200
+38,500
+177% +$2.39M ﹤0.01% 3191
2014
Q3 		$1.17M Sell
21,700
-15,200
-41% -$748K ﹤0.01% 5641
2014
Q2 		$1.64M Buy
36,900
+13,500
+58% +$551K ﹤0.01% 5042
2014
Q1 		$813K Buy
+23,400
New +$745K ﹤0.01% 5880

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Jeff Yass's CBPO Position: Q1 2021 in Review

Jeff Yass sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 4,984 shares — an estimated $589K sold.

Jeff Yass first reported a position in CBPO in Q2 2014 and held it in 23 quarters. The position peaked at $32.6M in Q3 2019. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Jeff Yass reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Jeff Yass sold 4,984 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $589K.
  • Jeff Yass first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 23 quarters.
  • Jeff Yass's China Biologic Products Holdings, Inc. position peaked at $32.6M in Q3 2019.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.